IONS - Biogen also drops collaboration with Ionis on Angelman syndrome candidate
2024-05-16 13:47:53 ET
More on Biogen, Ionis Pharmaceuticals
- Biogen: Reasons To Be Cheerful After Upbeat Q1 Earnings
- Biogen: Don't Overthink This One
- Biogen and Ionis drop ALS candidate after trial setback
- Eisai projects major growth for Alzheimer's therapy Leqembi
- Ionis Pharmaceuticals, Inc. (IONS) Q1 2024 Earnings Call Transcript